| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/20/2001 | WO2001096866A1 Toxicity typing using liver stem cells |
| 12/20/2001 | WO2001096865A1 Toxicity typing using mesenchymal stem cells |
| 12/20/2001 | WO2001096864A2 A method for detecting a lipoprotein-acute phase protein complex |
| 12/20/2001 | WO2001096862A2 Method for increasing luminescence assay sensitivity |
| 12/20/2001 | WO2001096857A2 Method and apparatus for combined magnetophoretic and dielectrophoretic manipulation of analyte mixtures |
| 12/20/2001 | WO2001096846A1 Gas concentration sensor, hydrogen purification unit using this and fuel cell system |
| 12/20/2001 | WO2001096845A1 Glass transition temperature measurement system |
| 12/20/2001 | WO2001096844A1 A method for the non-invasive measurement of properties of meat |
| 12/20/2001 | WO2001096834A2 Biosensor and deposit sensor for monitoring biofilm and other deposits |
| 12/20/2001 | WO2001096833A1 Method and device for measuring air pollution |
| 12/20/2001 | WO2001096832A1 Quasi-static viscometer |
| 12/20/2001 | WO2001096831A1 Hematology composition using preserved white blood cells |
| 12/20/2001 | WO2001096830A2 Pathology grossing board |
| 12/20/2001 | WO2001096610A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | WO2001096608A1 Detection of nucleic acids by type-specific hybrid capture method |
| 12/20/2001 | WO2001096605A2 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 12/20/2001 | WO2001096603A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/20/2001 | WO2001096602A2 Methods and materials to determine the p53 status of a sample by determining the binding of p53 to a vector |
| 12/20/2001 | WO2001096601A2 Neurotransmission disorders |
| 12/20/2001 | WO2001096597A2 High throughput screening of compounds for biological activity |
| 12/20/2001 | WO2001096596A2 Compositions containing a urea derivative dye for detecting an analyte |
| 12/20/2001 | WO2001096593A2 Novel motor proteins and methods for their use |
| 12/20/2001 | WO2001096574A1 Novel enzyme gene and its expression product |
| 12/20/2001 | WO2001096563A1 Scramblase 2 |
| 12/20/2001 | WO2001096562A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | WO2001096559A2 Regulatable, catalytically active nucleic acids |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | WO2001096551A2 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096540A2 Hepatitis c protease exosite for inhibitor design |
| 12/20/2001 | WO2001096528A2 Human tumor necrosis factor delta and epsilon |
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096383A2 High fluorescent intensity cross-linked allophycocyanin |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096025A2 Systems and methods for cell subpopulation analysis |
| 12/20/2001 | WO2001096023A2 Dielectrically-engineered microparticles |
| 12/20/2001 | WO2001096018A2 Apparatus and method for evaluating a test fluid |
| 12/20/2001 | WO2001095990A1 Apparatus and method for extracting and analyzing gas |
| 12/20/2001 | WO2001095860A2 Probes for chondrogenesis |
| 12/20/2001 | WO2001095784A2 Diagnostic kit for invitro detection of hepatitis c |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001069198A3 Assessing steels for undesirable phases |
| 12/20/2001 | WO2001064751A3 High potency recombinant antibodies and method for producing them |
| 12/20/2001 | WO2001062953A3 Electrochemical method for detecting nucleic acids |
| 12/20/2001 | WO2001062245A3 Bilirubin or biliverdin degradation fragments |
| 12/20/2001 | WO2001062206A3 N-cadherin modulated migration, invasion, and metastasis |
| 12/20/2001 | WO2001059461A3 Diagnosis or prediction of headache |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001057533A3 Detection and differentiation of bacteria using electrical detection methods |
| 12/20/2001 | WO2001055725A3 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 12/20/2001 | WO2001055035A3 Device for treating water |
| 12/20/2001 | WO2001053518A3 Method of assessing the viability of a cell |
| 12/20/2001 | WO2001053509A3 Biocidal molecules, macromolecular targets and methods of production and use |
| 12/20/2001 | WO2001051919A3 High-throughput formation, identification, and analysis of diverse solid-forms |
| 12/20/2001 | WO2001051045A3 Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001049823A3 Assays for detection of bacillus anthracis |
| 12/20/2001 | WO2001048484A3 Screening for host-molecules interacting with parasite-sge-related compounds |
| 12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
| 12/20/2001 | WO2001046456A3 Biological sensor |
| 12/20/2001 | WO2001046121A3 Exciplexes |
| 12/20/2001 | WO2001044809A3 Evaluation of biological agents in living target cells |
| 12/20/2001 | WO2001044292A3 Wasp (wiskott-aldrich syndrome protein) family protein fragments, and use thereof |
| 12/20/2001 | WO2001044266A3 Nucleic acid compounds and screening assays using the same |
| 12/20/2001 | WO2001040796A3 Glycoarrays on the surface of biochips |
| 12/20/2001 | WO2001038568A3 Automated method for identifying related biomolecular sequences |
| 12/20/2001 | WO2001034292A3 Macroporous media for biological application prepared by freeze drying |
| 12/20/2001 | WO2001031055A3 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001029207A8 Antiuracil monoclonal antibody |
| 12/20/2001 | WO2001027242A3 Methods for identifying inhibitors of methionine aminopeptidases |
| 12/20/2001 | WO2001025457A3 Gmp synthetase derived from plants |
| 12/20/2001 | WO2001002552A3 Double transgenic animals as models for neurodegenerative disease |
| 12/20/2001 | WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 12/20/2001 | WO2000068661A3 Detection of cellular exposure to addictive drugs |
| 12/20/2001 | WO2000061806A3 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000017103A9 Inventory control |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | WO1999028506A3 Cancer susceptibility mutations of brca2 |
| 12/20/2001 | US20010053959 Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053556 Miniature immuno-optical rapid analyte sensor platform |
| 12/20/2001 | US20010053553 Evaluation of reproductive therapy; monitor hormone levels humans, contrast with control, evaluate fertility classification |
| 12/20/2001 | US20010053552 Method and apparatus for measuring hemostasis |
| 12/20/2001 | US20010053551 Method for quantitatively analyzing fragmented red blood cells |
| 12/20/2001 | US20010053540 Forming biocompatible label; provide nucleotide sequences, denature, attach compound which prevents crystalization, monitor denatured nucleotide sequences |
| 12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053535 Biosensor and related method |
| 12/20/2001 | US20010053534 Early diagnosis of cancerous and precancerous conditions by leakage of signature peptides and carbohydrates into the bloodstream |